DoD Lung Cancer Career Development Award

 

The Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery. Submissions from and partnerships with investigators at Military Treatment Facilities (MTFs), military labs, the Department of Veterans Affairs (VA) Medical Centers and research laboratories are strongly encouraged. Preliminary data is not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Key elements of this award are as follows: • Principal Investigator (PI): PIs must be research- or physician-scientists at an early stage of their independent research careers. PIs must be within 5 years of their first faculty appointment (or equivalent), and exhibit a strong desire to pursue a career in lung cancer research. • Mentorship: The mentor must be an experienced lung cancer researcher as demonstrated by a strong record of funding and publications in lung cancer research. In addition, the mentor must demonstrate a commitment to developing the PI’s career in lung cancer research. • Career Development: A Career Development Plan is required and should be prepared with appropriate guidance from the mentor. A clearly articulated strategy for acquiring the necessary skills, competence, and expertise to have a career at the forefront of lung cancer research should be included. The plan should outline how the PI will gain experience and training in lung cancer research. Because career development is the focus of this award, the PI’s institution must demonstrate a commitment to the PI through a minimum of 40% protected time for the proposed research, though more protected time is highly desirable. Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths from lung cancer. • Relevance to Military Beneficiaries: The application should clearly articulate how the proposed research is relevant to service members, Veterans, their families, and other military beneficiaries.

Deleted 10/17/2014 (Archived.) W81XWH-14-LCRP-CDA Agency: Department of Defense
Office: U.S. Army Medical Research Acquisition Activity Cooperative Agreement, Grant 3 09/17/2014 This program does not have cost sharing or matching requirements. Phone: 301-682-5507
Email: help@eBRAP.org
help@eBRAP.org $1,152,000.00